MedTrace Logo

Evaluation of the Phantom X Implantable EMG Sensor System for Myoelectric Prosthesis Control

NCT07325708 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-01-08

No results posted yet for this study

Summary

The CYBORG Study is a first-in-human clinical investigation evaluating the safety and performance of the Phantom X System, an implantable electromyography (EMG) sensor array designed to provide control of upper-limb prostheses. The study will assess surgical feasibility, device function, signal quality, and the system's ability to support intuitive prosthetic control during functional tasks. Participants will undergo implantation of the Phantom X sensors and complete a series of in-clinic visits to assess functional performance of the Phantom X system. Patient-reported outcomes will also be collected at various timepoints.

Conditions

  • Upper Limb Amputation Below Elbow (Injury)
  • Wrist Disarticulation
  • Transradial Amputation

Interventions

DEVICE

Phantom X multielectrode EMG sensor array implant for upper limb prosthesis control

Participants receive the Phantom X implantable EMG sensor array and telemetry module to enable myoelectric control of an upper-limb prosthesis.

Sponsors & Collaborators

  • Cabrini Health, Melbourne, Australia

    collaborator UNKNOWN

  • ProMotion Prosthetics, Moorabbin, Australia

    collaborator UNKNOWN

  • Phantom Neuro Inc.

    lead INDUSTRY

Principal Investigators

  • Michael Lo, MBBS, FRACS, BSc (Hons) · Cabrini Private Hospital, Malvern, Australia

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2026-12-31
Completion
2027-06-30
FDA Device
Yes

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07325708 on ClinicalTrials.gov